How to rule out botulism in a 10-month-old infant given honey cough syrup who is now favoring one side?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ruling Out Botulism in a 10-Month-Old Given Honey Cough Syrup

A 10-month-old infant who has consumed honey cough syrup and is now favoring one side should be immediately evaluated for infant botulism, with urgent consultation with the California Department of Public Health Infant Botulism Treatment and Prevention Program to arrange for BabyBIG® administration. 1

Clinical Assessment for Infant Botulism

Key Symptoms to Evaluate

  • Descending paralysis pattern:
    • Assess for asymmetric weakness (favoring one side)
    • Evaluate cranial nerve function (facial weakness, ptosis)
    • Check for bulbar palsies (poor feeding, weak cry, difficulty swallowing)
    • Look for pupillary response abnormalities 2
  • Constipation: Often the first symptom, preceding neurological symptoms
  • Respiratory function: Monitor closely for signs of respiratory compromise
  • Other symptoms: Poor feeding, lethargy, decreased movement, hypotonia

Diagnostic Approach

  1. Clinical diagnosis is primary: The diagnosis of infant botulism is primarily clinical 1
  2. Laboratory confirmation:
    • Stool sample for C. botulinum organism and toxin detection
    • Electromyography (EMG) if available 2

Treatment Algorithm

  1. Immediate consultation:

    • Contact local or state health department for emergency clinical consultation
    • Call the California Department of Public Health Infant Botulism Treatment and Prevention Program to arrange for BabyBIG® 1
  2. Antitoxin administration:

    • BabyBIG® (Human Botulism Immune Globulin) is the treatment of choice for infant botulism
    • Early administration (within 3 days of hospital admission) reduces hospital stay, intensive care duration, mechanical ventilation, and tube/IV feeding 1
    • Note: If the infant is part of a group outbreak, they likely have ingested preformed toxin rather than having intestinal colonization, and should receive BAT (Botulism Antitoxin Heptavalent) instead of BabyBIG® 3, 1
  3. Supportive care:

    • Continuous respiratory monitoring and support as needed
    • Nutritional support via nasogastric or intravenous feeding until swallowing function returns
    • Monitor for complications: cardiac rhythm abnormalities, blood pressure changes, urinary retention, constipation/ileus 1

Important Considerations

  • Honey exposure is a key risk factor: Honey is a known source of C. botulinum spores and should never be given to infants under 12 months of age 1, 4
  • Time is critical: Treatment effectiveness is directly related to how quickly antitoxin is administered after symptom onset
  • Complete recovery is possible: With appropriate treatment, most infants recover completely 1

Common Pitfalls to Avoid

  • Delayed diagnosis: Infant botulism may be mistaken for sepsis, meningitis, or other neurological disorders
  • Failure to recognize the honey connection: Always ask specifically about honey exposure, including in medications or remedies 4
  • Inappropriate antitoxin selection: Remember that true infant botulism (intestinal colonization) requires BabyBIG®, while ingestion of preformed toxin requires BAT 3, 1
  • Inadequate respiratory monitoring: Respiratory failure can develop rapidly and requires vigilant monitoring

By following this approach, you can effectively rule out or confirm infant botulism and ensure appropriate treatment for this potentially life-threatening condition.

References

Guideline

Treatment of Infant Botulism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A taste of honey.

Journal of paediatrics and child health, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.